2009
DOI: 10.1016/j.chom.2009.05.011
|View full text |Cite
|
Sign up to set email alerts
|

Bacterial Adhesins in Host-Microbe Interactions

Abstract: Most commensal and pathogenic bacteria interacting with eukaryotic hosts express adhesive molecules on their surfaces that promote interaction with host cell receptors or with soluble macromolecules. Even though bacterial attachment to epithelial cells may be beneficial for bacterial colonization, adhesion may come at a cost because bacterial attachment to immune cells can facilitate phagocytosis and clearing. Many pathogenic bacteria have solved this dilemma by producing an antiphagocytic surface layer usuall… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
480
1
10

Year Published

2010
2010
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 543 publications
(496 citation statements)
references
References 129 publications
5
480
1
10
Order By: Relevance
“…Non-specific binding involves electrostatic and hydrophobic interactions of lower affinity than for specific binding. The localization and mechanisms of binding to the epithelial surface have been studied previously in enteropathogenic bacteria such as E. coli and Salmonella, and type I fimbriae are frequently involved in this adhesion, generally using mannose as a receptor (Kline et al, 2009). A number of different approaches have been taken over the years to inhibit adhesion of pathogenic bacteria, and addition of exogenous sugars and inhibition of fimbria assembly are two strategies that have been studied (Cusumano & Hultgren, 2009).…”
Section: Discussionmentioning
confidence: 99%
“…Non-specific binding involves electrostatic and hydrophobic interactions of lower affinity than for specific binding. The localization and mechanisms of binding to the epithelial surface have been studied previously in enteropathogenic bacteria such as E. coli and Salmonella, and type I fimbriae are frequently involved in this adhesion, generally using mannose as a receptor (Kline et al, 2009). A number of different approaches have been taken over the years to inhibit adhesion of pathogenic bacteria, and addition of exogenous sugars and inhibition of fimbria assembly are two strategies that have been studied (Cusumano & Hultgren, 2009).…”
Section: Discussionmentioning
confidence: 99%
“…Why distal colon is different is not understood, but one could speculate that this has to do with selection of the commensal flora. Bacteria often carry adhesins, usually at the tip of their fimbrie, that bind mucins (36). This was recently illustrated by the isolation of an adhesin from the commensal bacteria Lactobaccilus rhamnosus (37).…”
Section: Muc2 Glycosylation In Human Sigmoid Colonmentioning
confidence: 99%
“…However, the large number of different adhesin genes in an organism's genome suggests that there are multiple pathways for bacterial adherence (Brzuszkiewicz et al, 2006). This redundancy limits the use of adhesins as vaccine candidates (Kline et al, 2009). In addition, different adhesins are not produced simultaneously and continuously and require different environmental cues for expression, and many exist as antigenic variants (Klemm & Schembri, 2000).…”
Section: Adhesins As Vaccine Candidatesmentioning
confidence: 99%
“…A review by Kline et al (2009) highlighted adhesive proteins as protective antigens. These include: an E. coli FimH adhesin-based vaccine against cystitis in a primate model (Langermann et al, 2000), the E. coli Dr fimbrial antigen against urinary tract infection in mice (Goluszko et al, 2005), the Salmonella atypical fimbriae B chaperone (SafB) complexed with the SafD adhesin against invasive Salmonella enteritidis infection (Strindelius et al, 2004), a synthetic-peptide consensus-sequence vaccine (Cs1) against type IV pilus of P. aeruginosa in a mouse model (Kao et al, 2007) and a combination of three group B Streptococcus (GBS) pilus variants that mediate protection in mice against all tested GBS challenge strains (Margarit et al, 2009).…”
Section: Adhesins As Vaccine Candidatesmentioning
confidence: 99%
See 1 more Smart Citation